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Abstract We have recently reported that GK12 is acylated with
palmitic acid [Veit et al., FEBS Lett. 339 (1994) 160^164]. Here
we identify cysteine 11 as the sole palmitoylation site and assess
the function of GK12 palmitoylation after expression of wild type
and acylation-deficient mutant in insect cells. Our experimental
approach yielded the following results. (1) Palmitoylation of
GK12 has no influence on the subunit interactions. (2)
Palmitoylation promotes membrane binding of GK12 when this
protein is expressed alone. Membrane attachment of the
heterotrimer occurs independent of the presence of fatty acids
in GK12. (3) Assays for agonist-stimulated binding of
[35S]GTPQS after expression of the human thrombin receptor
(PAR1) along with GK12 and the LQ subunits revealed a 70%
inhibition with the palmitoyl-deficient mutant.
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1. Introduction
Heterotrimeric regulatory guanine nucleotide binding pro-
teins (G-proteins) are central in the transducing of signals
from activated receptors to appropriate intracellular e¡ectors
such as enzymes and ion channels [1^4]. Each heterotrimer
consists of a relatively hydrophilic K subunit, which exchanges
GDP for GTP upon activation by a receptor, and the rela-
tively hydrophobic LQ complex. In order to function as signal
transducers, G-proteins have to be associated with the cyto-
plasmic face of the plasma membrane. This membrane asso-
ciation may be partly mediated by the highly lipophilic LQ
subunits [5,6]. On the other hand, essentially all GK subunits
are modi¢ed by covalently attached myristic and/or palmitic
acids [7^9]. It is now widely accepted that these lipid modi¢-
cations (especially palmitoylation) greatly facilitate and are in
some cases essential for anchoring GK subunits to the mem-
brane or specifying their membrane localization, or both [10^
12]. Palmitoylation is a dynamic modi¢cation of proteins,
unlike myristoylation, which is usually an irreversible cotrans-
lational modi¢cation. Therefore it has been suggested that
cycles of palmitoylation and depalmitoylation could also reg-
ulate the signaling activity and membrane association of G-
protein K subunits [12^14]. In the case of GKs and GKq acti-
vation by agonist stimulation leads to increased turnover of
palmitate [15^17]. Treatment with cholera toxin also promotes
palmitate turnover of GKs [16]. In contrast, turnover of bound
palmitate on GKi and GKs is decreased by co-expression of
GLQ, which inhibits activation [6,18]. Accumulation of the
depalmitoylated form of GKs in chronically morphine-treated
A431/W13 cells increases intrinsic GKs activity and promotes
GKs/adenylyl cyclase interaction [19]. Palmitoylation of GKz
decreases the a⁄nity of Gz GTPase activating protein for the
GTP-bound form of GKz thereby inhibiting the rate of GTP
hydrolysis [20]. Preventing palmitoylation of GKz enhances
Gz-mediated inhibition of adenylyl cyclase [9].
Here we report experiments designed to examine the e¡ects
of acylation on membrane attachment and signaling function
of a member of the more recently identi¢ed fourth subfamily
of K subunits, GK12. The pertussis toxin-insensitive GK12 and
GK13 subunits are expressed ubiquitously [21] and show rela-
tively slow guanine nucleotide exchange and hydrolysis
[22,23]. GK12=13 proteins are involved in mitogenesis and
transformation probably through activation of c-Jun N-termi-
nal kinase pathways [24,25] as well as in regulation of Na-H
exchange [26]. Recent work on GK12=13 has focussed on their
oncogenic potential, when overexpressed in cells [27,28]. The
activated receptors of thromboxane A2 and thrombin couple
to GK12 and GK13 in humane platelet membranes [29], and
GK13 interacts with the angiotensin AT1A receptor in rat por-
tal vein myocytes [30]. Recently we have demonstrated that
both GK12=13 subunits are palmitoylated in ester-type linkage
and that the acylated form of GK12 is largely membrane-
bound [31].
In the present study we identify Cys residue 11 as the sole
palmitoylation site on GK12 and show that acylation is not
necessary for the heterotrimer formation and its binding to
the membrane. We also investigate the selectivity in coupling
of the thrombin receptor to GK12 wild type as well as its
acylation-de¢cient mutant by agonist-promoted binding of
[35S]guanosine 5P-(3-O-thio)triphosphate (GTPQS) [32] and
present evidence that a lack of palmitate in the GK12 subunit
results in drastically reduced receptor coupling.
2. Materials and methods
2.1. Baculoviruses and site-directed mutagenesis
The construction of pVL1392 vector encoding the GK12 wild type
(GK12wt) was described previously [31]. The GK12 mutant (GK12mut)
with the substitution of serine for cysteine 11 was performed with the
‘Chameleon’ double-stranded, site-directed mutagenesis kit (Strata-
gene) according to the manufacturer’s protocol using an oligonucleo-
tide containing the mutation corresponding to the above substitution.
The ¢nal mutant was veri¢ed by DNA sequencing. Recombinant ba-
culoviruses encoding L1, Q2 and Q3 subunits were kindly provided by P.
Gierschik (Ulm), and those encoding the human thrombin receptor
and GK12 were recently described [31,33].
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2.2. Metabolic labeling and immunoprecipitation
Spodoptera frugiperda (Sf9) cells in 3.5 mm dishes were infected
with recombinant baculoviruses at a multiplicity of infection of at
least one for each type of virus. After 48 h Sf9 cells were labeled
with Tran[35S] label (s 1000 Ci/mmol, ICN) or [3H]palmitic acid
(30^60 Ci/mmol, DuPont NEN) and immunoprecipitated as described
previously [31]. Antibodies AS1905 raised against the N-terminal pep-
tide corresponding to the deduced amino acid sequence of GK12 (ami-
no acids 1^21), antibodies AS398 against L subunits (L1^L4) and
AS292 against the Q subunits (Q2+Q3) were used for immunoprecipita-
tion [34].
2.3. Cell fractionation
Infected and methionine labeled Sf9 cells were washed once with
PBS, resuspended in extraction bu¡er (10 mM Tris-HCl (pH 7.4); 1
mM EDTA; 150 mM NaCl; 1 mM DTT) and homogenized by so-
ni¢cation. The homogenate was centrifuged at 5000Ug for 5 min, and
the resulting supernatant fraction was centrifuged at 125 000Ug at
4‡C for 30 min. The membrane pellets were incubated in extraction
bu¡er containing 1% (w/v) sodium cholate for 1 h at 4‡C and centri-
fuged again at 125 000Ug for 30 min. The ¢nal fractions were diluted
in 2URIPA bu¡er (2% Triton X-100; 2% deoxycholate, 0.2% SDS;
300 mM NaCl; 40 mM Tris-HCl (pH 7.4); 20 mM EDTA; 20 mM
iodoacetamide) prior to immunoprecipitation.
2.4. Assay for [35S]GTPQS binding
Agonist-promoted binding of [35S]guanosine 5P-(3-O-thio)triphos-
phate to GK12 wild type as well as the fatty acid-de¢cient mutant
was performed according to the method described by Barr et al.
[32]. Brie£y, membranes from Sf9 cells expressing the thrombin re-
ceptor (PAR1) and/or G-protein subunits were resuspended in 55 Wl
of 50 mM Tris-HCl (pH 7.4) containing 2 mM EDTA, 100 mM NaCl,
3 mM MgCl2 and 1 WM GDP. After adding [35S]GTPQS (1300 Ci/
mmol, DuPont NEN) to a ¢nal concentration of 30 nM samples were
incubated for 5 min at 30‡C in the absence or presence of thrombin
receptor activator SFLLRNPNDKYEPF (Sigma). The reaction was
terminated by adding 600 Wl of 50 mM Tris-HCl (pH 7.5) containing
20 mM MgCl2, 150 mM NaCl, 0,5% NP-40, 200 Wg/ml aprotinin, 100
WM GDP and 100 WM GTP for 30 min on the ice. The samples were
incubated for 20 min with 150 Wl of a 10% suspension of Pansorbin
cells (Calbiochem) to remove non-speci¢cally bound proteins followed
by 1 h at 4‡C with 10 Wl of a GK12 subunit-directed antiserum, which
had been preincubated with 100 Wl of 10% suspension of protein A-
Sepharose. Immunoprecipitates were washed three times, boiled in 0.5
ml of 0.5% SDS, then 4 ml of Ecolite+ (ICN) was added and radio-
activity measured by scintillation spectrometry.
3. Results and discussion
3.1. Palmitoylation site on GK12
We had previously shown that GK12 is acylated and the
fatty acid bond is sensitive to neutral hydroxylamine and re-
ducing agents, demonstrating a thioester-type fatty acid link-
age [31]. We proposed that the site of palmitoylation of GK12
subunit is located at position 11, since this is the only Cys
residue in the ¢rst 240 N-terminal residues of this protein. A
role for this Cys residue in the palmitoylation was tested by
mutagenesis of the codon for cysteine to one for serine. Re-
sults of labeling experiments with [35S]methionine shown in
Fig. 1 (left panel) indicate that GK12 Cys mutant was as e⁄-
ciently expressed as GK12wt. However, [3H]palmitate was in-
corporated only into the wild type protein but not the mutant,
demonstrating the essential involvement of this Cys residue 11
in palmitoylation of GK12 (Fig. 1, right panel) and con¢rming
the very recent data by Jones and Gutkind [35]. The amino-
terminus of GK12 is quite distinct when compared to other
acylated K subunits and does not contain the Met-Gly-Cys
motif, which has been proposed as acylation consensus se-
quence for most other acylated GK subunits [8] and some
members of the Src-related family of tyrosine kinases [36].
The Met-Gly-Cys amino-terminal sequence possibly repre-
sents a motif for dual modi¢cation with both myristic and
palmitic acids (except for GKs, which is modi¢ed by palmitate
[5]). The case of GKq=11, which is only palmitoylated and
which contains putative palmitoylation sites at positions 9
and 10 [13,37,38], and the case of GK12 reported here indicate
that the distance between the N-terminus and acylation sites
in palmitoylated GK subunits may be variable.
3.2. Role of palmitoylation for interaction with LQ subunits
and membrane association
The role of palmitoylation of various K subunits for heter-
otrimer formation with LQ subunits has been subject of several
studies some of which exclude the involvement of fatty acids
with heterotrimerization [39], while others favor a causative
link [6,16]. We extended such investigations to GK12 and an-
alyzed the interaction of GK12wt or GK12mut with LQ by ex-
amining the capacity of antibodies directed against the indi-
vidual subunits (K, L or Q) to immunoprecipitate all three
proteins after co-expression in Sf9 cells. When the LQ subunits
were expressed alone they could not be immunoprecipitated
with anti-K antibodies (Fig. 2A, second and third lanes).
However, after co-expression of GK12wt, both L and Q pro-
teins were also detectable with GK-directed antibodies (Fig.
2A, last two lanes). Immunoprecipitation of Sf9 cells ex-
pressed either K12wt or LQ or all three subunits together
with antibodies directed against the L or Q subunit yielded
similar results (not shown). When GK12mut was expressed
alone or co-expressed with LQ subunits the immunoprecipita-
tion pattern with antibodies directed against either the K or L
or Q subunit was quite similar to that for GK12wt. This is
shown in Fig. 2B for the immunoprecipitates brought down
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Fig. 1. Mutation of Cys-11 on GK12 abolishes palmitoylation. GK12
wild type (GK12wt) and GK12 with cysteine residue 11 replaced by
serine (GK12mut) were expressed in Sf9 cells, labeled with either
[35S]methionine/cysteine (left panel) or [3H]palmitic acid (right panel)
and subjected to immunoprecipitation, SDS-PAGE and £uorogra-
phy. Exposure time is 1 day for labeling with [35S]methionine/cys-
teine and 4 weeks for labeling with [3H]palmitate. The N-terminal
sequences of GK12wt and GK12mut are given in single-letter code
[42].
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with anti-GK12 antibodies. These data indicate that GK12mut
also forms a complex with LQ subunits and suggests that pal-
mitoylation of Cys residue 11 is not necessary for interaction
of GK12 with LQ.
We demonstrated previously that GK12 expressed in Sf9
cells accumulates in both membranes and cytosol. However,
only the membrane-associated K subunits had [3H]palmitate
incorporated [31] indicating the presence of at least two dis-
tinct populations of this protein at di¡erent intramolecular
locations. In order to determine whether palmitoylation is
critical for attaching GK12 to membranes, we compared the
subcellular distribution of GK12wt and its non-acylated mu-
tant (GK12mut) after infection of Sf9 cells with the respective
recombinant baculoviruses alone or during co-expression of
both the L1 and Q2 subunits. To exclude the possibility that
non-functional (denatured and aggregated) GK12 protein may
mimic a true membrane fraction, high speed membrane pellets
were extracted with 1% sodium cholate before immunopre-
cipitation and SDS-PAGE. The same amount (30^40%) of
each GK12wt and GK12mut protein associated with mem-
branes was extractable with detergent. (Some part of recombi-
nant GK12 proteins was denatured and aggregated, as indi-
cated by resistance to extraction with 1% sodium cholate.)
Thus, the resulting protein bands shown in Fig. 3A (lines
designated Mem) represent truly membrane-bound GK12.
Densitometric analysis revealed that in the absence of LQ sub-
units nearly one half of GK12wt and more than two thirds of
GK12mut are present in the soluble fraction (cytosolic GK12),
indicating the importance of palmitoylation for membrane
binding (Fig. 3B). However, co-expression of LQ targeted
more than half of GK12mut to the membrane, making the
intracellular distribution of the non-palmitoylated mutant
similar to that of wild-type (Fig. 3A,B).
Taken together the above results demonstrate that the non-
palmitoylated GK12 subunit can form heterotrimers with the
LQ subunits and at the same time this interaction restores
membrane localization of GK12. Thus, in line with reports
on other types of K subunits [18], membrane association of
GK12 is a complex process. Membrane binding of GK12 re-
quires acylation only when it is solitary, while protein-protein
interactions predominate in membrane attachment when it is
trimerized with the LQ subunits.
3.3. In£uence of palmitoylation on coupling of G12 to the
thrombin receptor
We compared the interaction of the thrombin receptor with
normal and fatty acid-de¢cient GK12 subunits in membrane
preparations from infected cells. Co-expression of receptor
and the K subunit (alone or together with LQ) in Sf9 cells
and measurement of agonist-promoted binding of
[35S]GTPQS provides a useful experimental approach for as-
sessing the selectivity of receptor-G-protein coupling [32]. Us-
ing this system we found for normal G12 (i.e. K12wt, L1 and Q2)
a 12.6-fold increase in the binding of [35S]GTPQS after co-
expression of thrombin receptor in response to the agonist
(Fig. 4). Expression of GK12wt alone also demonstrated in-
creased binding of [35S]GTPQS after exposition to agonist,
although at a much reduced level (Fig. 4). In this case the
binding e⁄ciency varied considerably, and we propose that
variable amounts of endogenous GLQ in di¡erent membrane
preparations could be responsible for this variable stimula-
tion. When GK12mut was expressed beside the thrombin re-
ceptor but without LQ subunits, the agonist had no signi¢cant
e¡ect on binding. Co-expression of LQ subunits reconstituted
the capacity of GK12mut to bind [35S]GTPQS signi¢cantly, but
stimulation by agonist was reduced to less than 30% when
compared to control values with GK12wt (Fig. 4). This reduc-
tion was not due to di¡erent expression level of GK12 or
retarded incorporation of [35S]GTPQS into GK12mut, because
the amount of GK12wt and GK12mut in membrane prepara-
tions was the same and both G12wt as well as the acylation-
de¢cient mutant showed similar kinetics (not shown).
Our results are consistent with the current notion that the
thrombin receptor PAR1 couples to G-proteins of the G12
family [29,32], and they suggest that palmitoylation (or pres-
ence of Cys residue 11) signi¢cantly contributes to normal
communication of the thrombin receptor with GK12. The pre-
cise role of the palmitoylated cysteine residue is unclear. It
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Fig. 2. Assay for palmitate involvement in heterotrimerization by subunit co-precipitation using anti-GK12 antibodies. A: Insect cells expressing
either GK12wt or GL1Q2, or GL1Q3 or all three subunits together were labeled with [35S]methionine/cysteine. After lysis, recombinant proteins
were immunoprecipitated with antibody directed against GK12 subunits and subjected to SDS-PAGE and £uorography. B: Results of expressing
GK12mut alone or together with either GL1Q2 or GL1Q3 after immunoprecipitation with anti-GK12 antibodies.
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may be involved in formation of intramolecular contacts with-
in GK12 or in intermolecular interactions with the receptor. It
has been reported that Cys-3 of GKo (palmitoylated cysteine
analogous to Cys-11 in GK12) interacts directly with a masto-
paran derivative, a small amphipathic peptide which activates
G-proteins [40]. Likewise, the acylated Cys-11 of GK12 could
also in£uence interactions with the thrombin receptor in an
acylation-dependent manner.
Finally, palmitoylation has been shown to be a dynamic
modi¢cation and cycles of acylation and deacylation may
play a role in regulating the activity of some GK proteins
[17,41,42]. Supporting this view, we have also observed that
palmitoylation of recombinant GK12 undergoes turnover
although, unlike previous observation with GKs [43], depalmi-
toylation of GK12 is relatively slow and is not increased by
treatment with agonist (not shown). Our results presented
here on GK12 are in line with the general understanding that
the dynamic nature of palmitoylation is a common feature of
GK subunits which contributes to the mechanisms of regulat-
ing signaling by G-proteins.
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Fig. 4. Receptor-promoted binding of [35S]GTPQS to GK12wt and
GK12mut. Membranes were prepared from Sf9 cells expressing pro-
teins as indicated below. [35S]GTPQS binding was assessed after in-
cubation with or without 30 WM thrombin receptor activator
(SFLLRNPNDKYEPF) followed by immunoprecipitation using
GK12-speci¢c antiserum. Data points represent the mean þ S.E.M.
from four independent experiments. Statistically signi¢cant increases
from values obtained with K12wt+LQ or with K12mut+LQ without
thrombin receptor are noted (*P6 0.01).
Fig. 3. Intracellular distribution of GK12wt and GK12mut. A: Insect cells expressing either GK12wt or GK12mut alone or together with L1 and
Q2 subunits were labeled with [35S]methionine/cysteine. After lysis and separation into cytosolic (Cyt) and membrane (Mem) fractions GK12 pro-
tein was immunoprecipitated from each fraction with antibodies directed against GK12 and subjected to SDS-PAGE and £uorography. Results
are representative of four independent experiments. B: Result of densitometric analysis of the £uorogram shown in A and of additional £uoro-
grams from three independent experiments þ S.E.M.
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